$微创机器人-B(02252.HK)$ Finally on, but did not hit a new subscription. The market is not friendly to unprofitable start-ups, and expect a more comfortable price. Kingsley bio and minimally invasive robotics are the most focused directions for innovative drugs and innovative medical devices in the future. It is nothing more than the time and rhythm of the completion of the warehouse.
$微创机器人-B(02252.HK)$ The big Four are 10 years ahead of their time in technology, waiting for the world to catch up, and they have their own medical robots. Da Vinci launched its products in 2000 based on the underlying technology of the robot industry. The more cases there are, the more powerful they are.
$微创机器人-B(02252.HK)$Personal View of minimally invasive robot Several key points, not profitable, High ling IPO increase, JPMORGAN Chase sponsor, expected 50% callback, IPO for the previous investment rise range is still ok, speculation new mood has not recovered; In summary, in terms of playing new, the probability of winning is almost 50/50, the odds are not high, if the call back to break the resistance to save slightly bigger
$微创机器人-B(02252.HK)$Make money on short-term market sentiment. Since we are only new, we need to have a clear positioning, just to make money in the dark market or the first two days of the listing. So, listed the first time is up or down for us is the most important! Even if you think that the future of this new stock must be bright, the future must be a big bull, and we hit the new is not related to, because we can not wait for the distant future.
微创机器人-B股票讨论区
K线组合有望走出双底形态,技术指标KDJ已经金叉发散,预计短线股价仍有上行空间
专栏不段说:meta/fb都簽了他們?!元宇宙概念還有調整買入機會嗎?
4:25 unity业绩被错待,为什么元宇宙重要股有它?u.us 、mttr.us $Unity Software(U.US)$ $Matterport(MTTR.US)$ $Meta Platforms(FB.US)$ $英伟达(NVDA.US)$
19:46 元宇宙投资周期到底有多长?
22:00 为什么说疫苗相关股的逻辑被破坏掉了?腾盛(2137) $腾盛博药-B(02137.HK)$ 开拓药业(9939) $开拓药业-B(09939.HK)$ $辉瑞(PFE.US)$
29:43 QA 保利协鑫(3800) $协鑫科技(03800.HK)$ 、片仔癀(600436) $片仔癀(600436.SH)$
Finally on, but did not hit a new subscription. The market is not friendly to unprofitable start-ups, and expect a more comfortable price. Kingsley bio and minimally invasive robotics are the most focused directions for innovative drugs and innovative medical devices in the future. It is nothing more than the time and rhythm of the completion of the warehouse.
The big Four are 10 years ahead of their time in technology, waiting for the world to catch up, and they have their own medical robots. Da Vinci launched its products in 2000 based on the underlying technology of the robot industry. The more cases there are, the more powerful they are.
Several key points, not profitable, High ling IPO increase, JPMORGAN Chase sponsor, expected 50% callback, IPO for the previous investment rise range is still ok, speculation new mood has not recovered;
In summary, in terms of playing new, the probability of winning is almost 50/50, the odds are not high, if the call back to break the resistance to save slightly bigger
暂无评论